Microbiome, Mycobiome and Related Metabolites Alterations in Patients with Metabolic Syndrome—A Pilot Study

Metabolic syndrome (MetSyn) has a rapidly growing worldwide prevalence, affecting over 1 billion people. MetSyn is clustering many pathological conditions, which, untreated, could increase the risk and often lead to more severe metabolic defects such as type 2 diabetes and non-alcoholic fatty liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Gradisteanu Pircalabioru, Gratiela, Ilie, Iuliana, Oprea, Luciana, Picu, Ariana, Petcu, Laura Madalina, Burlibasa, Liliana, Chifiriuc, Mariana-Carmen, Musat, Madalina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951583/
https://www.ncbi.nlm.nih.gov/pubmed/35323661
http://dx.doi.org/10.3390/metabo12030218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951583/
https://www.ncbi.nlm.nih.gov/pubmed/35323661
http://dx.doi.org/10.3390/metabo12030218

Ejemplares similares